Aduro Biotech (ticker: $ADRO)

Haven't done much DD yet, but @StockInvest, @YahooFinance and @ZacksResearch think it's a buy.

Low barrier of entry with just $3.22/share, but I don't see a quick upside for a post-pandemic flip yet.

#stockstowatch #stockstobuy #stocks https://t.co/GBq2QOgACE